Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease02/01/2023 - 01/31/2026 (Key Person / Mentor)
NIH/National Diabetes & Digestive & Kidney Diseases1F31DK135378-01
Sexual dimorphism of acetaminophen-induced liver injury and regeneration07/01/2021 - 10/31/2022 (Key Person / Mentor)
NIH/National Diabetes & Digestive & Kidney Diseases5F31DK127606-02
A multi-modular approach for human pluripotent stem cell-based liver regeneration09/15/2020 - 07/31/2024 (PI)
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS1R01DK124361-01A1
Edited stem cell-based therapy with transcript therapy for AATD-associated liver disease07/01/2019 - 06/30/2022 (PI)
Alpha-1 Foundation
Use of Human Pluripotent Stem Cell-derived Hepatic Cells in Pediatric Liver Transplantation07/01/2017 - 05/31/2018 (PI)
March of Dimes